Skip to main content

bosentan

Generic: BOSENTAN·Brand: BOSENTAN, TRACLEER, Tracleer

bosentan: 2 clinical trials tracked.

bosentan evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about bosentan, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Healthy

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (2)

A Phase 1 Clinical Trial in Healthy Participants to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of TERN-701, the Effects of Food, Acid-Reducing Agents, and Drug-Drug Interactions, and the Relative Bioavailability of New Tablet Formulations of TERN-701

NCT07838987Registry updated 2026-09-24·Phase 1
Completed

Primary endpoint: Number of Participants Who Experience a Treatment Emergent Adverse Event (AE)

InterventionalRandomizedopen196 enrolledStarted 2023-12Completion 2026-061 site · United StatesTerns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

A Phase 1 Study of Gemcitabine, Nab-Paclitaxel, and Bosentan in Patients With Unresectable Pancreatic Cancer

NCT04158635Registry updated 2026-06-15·Phase 1
Suspended

Primary endpoint: Incidence of adverse events

Interventionalopen21 targetStarted 2021-09Completion 2027-031 site · United StatesCity of Hope Medical Center